Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
about
Prevalence and molecular epidemiology of methicillin-resistant Staphylococcus aureus in a tertiary Greek hospital.The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsEpidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitalsHealthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution.Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbBPerformance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout MutantsGenotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United StatesIn vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis.Disruption of staphylococcal aggregation protects against lethal lung injury.Prevalence and characteristics of methicillin-resistant Staphylococcus aureus in community residents of Japan.Hierarchy of human IgG recognition within the Staphylococcus aureus immunome
P2860
Q33918527-70485A02-B719-4833-A983-E3497FB94BAAQ34618696-8AC8BB4E-DA9C-4EA0-9E6F-D7E1EF996A60Q34999500-D2829745-4447-49E2-93F0-A8047E9FA328Q35654266-127F0950-F6F4-4AF2-B773-DD6A9E1A8BD4Q35927293-E9569E64-D37C-4A3F-B29E-09DFF620D77DQ36281391-5269646A-6D15-49EA-AE73-89D2F8C35593Q36434414-F51FBBC3-B591-47C6-A4A5-80A0A92BE6FDQ36489501-BF08B830-4170-4276-BDC9-B6DCF7CD41A8Q36644689-21D990C6-4E6B-42DE-9376-4F8CFB64DD91Q36812827-4091FDE0-41D2-42C2-BED3-A4CDBA9B1B77Q38674449-097F3471-074F-4C5E-9E1C-D17B8A22BC8DQ39565510-BD4A759B-92EF-44EC-A27A-19A0EEC321EDQ41507478-6F71095B-E67C-4062-B3BE-068F6E3F4055Q41561992-7A542C5F-1A9D-49D2-955A-F6AEE492A65CQ42788158-13F3F91B-E831-458D-9C31-27AF9D3E7D98Q50047637-FFA8477F-82DD-4CB2-9516-84F6B9D8CD98Q55004238-10A98439-0135-412F-BB36-35394557A7A9Q58763401-00FD12D2-6400-4759-AD93-A1716696D4BE
P2860
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Characterization of methicilli ...... tment of nosocomial pneumonia.
@ast
Characterization of methicilli ...... tment of nosocomial pneumonia.
@en
type
label
Characterization of methicilli ...... tment of nosocomial pneumonia.
@ast
Characterization of methicilli ...... tment of nosocomial pneumonia.
@en
prefLabel
Characterization of methicilli ...... tment of nosocomial pneumonia.
@ast
Characterization of methicilli ...... tment of nosocomial pneumonia.
@en
P2093
P2860
P921
P356
P1476
Characterization of methicilli ...... atment of nosocomial pneumonia
@en
P2093
Bo Shopsin
David J Farrell
Lalitagauri M Deshpande
Rodrigo E Mendes
Ronald N Jones
P2860
P304
P356
10.1128/JCM.02024-12
P407
P577
2012-09-12T00:00:00Z